Showing results (191-200 of 738) with videos related to
Sort By:
Pageof 74
The Journal of Antibiotics|November 1, 1983
Induction of beta-lactamase and penicillin-binding proteins in Escherichia coli by introduction of Streptomyces DNAH Nakazawa, M M Nakano, H OgawaraMolecular Carcinogenesis|January 1, 1990
Relationship between chemically induced Ha-ras mutation and transformation of BALB/c 3T3 cells: evidence for chemical-specific activation and cell type-specific recruitment of oncogene in transformationH Nakazawa, A M Aguelon, H YamasakiNihon Naibunpi Gakkai Zasshi|August 20, 1987
[Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases]S Mitsuhashi, R Yamasaki, S Miyazaki, et al.The Japanese Journal of Antibiotics|April 1, 1985
[Clinical studies of intravenous drip infusion of micronomicin. 1. Pharmacokinetics (Part 2). Intravenous Micronomicin Research Group]M Watanabe, I Saito, S Mitsuhashi, et al.Microbiology and Immunology|January 1, 1982
Purine metabolic enzymes in lymphocytes. I. Adenosine deaminase and purine nucleoside phosphorylase activities in mouse lymphocyte subpopulationsS Kurashige, Y Akuzawa, T Yoshida, et al.Antimicrobial Agents and Chemotherapy|April 1, 1988
Purification and characterization of human renal dehydropeptidase IS Mitsuhashi, A Fuse, H Mikami, et al.Infection|November 1, 1983
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensH Knothe, P Shah, V Krcmery, et al.Antimicrobial Agents and Chemotherapy|June 1, 1988
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinoloneK Fujimaki, T Noumi, I Saikawa, et al.Antimicrobial Agents and Chemotherapy|January 1, 1974
Relationship between chloramphenicol acetyltransferase activity and the number of resistance genesS Iyobe, M Kono, K Oara, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1993
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactamT Muratani, E Yokota, T Nakane, et al.Pageof 74